Company Profile
Argenx Stock Price, News & Analysis
- Ticker:
- ARGX
- Exchange:
- NASDAQ
- Sector:
- 抗体技术平台
- Location:
- Headquartered in the United States and listed on NASDAQ, Argenx is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
853.40 USD (-5.57%)
Close
Last updated: June 23, 2026 at 00:00
53.07B USD
Market cap
Why the stock is moving
ARGX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Argenx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Argenx is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Argenx follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Argenx sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Argenx (ARGX)?
Argenx (ARGX) most recently closed at 853.40 USD, a -5.57% move versus the previous session.
What is the market cap of Argenx (ARGX)?
Argenx currently has a market capitalization of 53.07B USD on BioPharmSignal.
What does Argenx do?
Argenx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is ARGX stock listed?
Argenx (ARGX) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Argenx is followed within the biotech universe for its exposure to catalyst-driven execution., 抗体技术平台.
What is Argenx?
Argenx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Argenx targeting with Argenx?
Argenx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.